Logo image
Rare case of pancrelipase therapy-induced neutropaenia
Journal article   Open access   Peer reviewed

Rare case of pancrelipase therapy-induced neutropaenia

Richard Amoateng, Brent Hardman, Catherine Liu and Scarlett Austin
BMJ case reports, v 14(3), pe241799
22 Mar 2021
PMID: 33753395
url
https://doi.org/10.1136/bcr-2021-241799View
Published, Version of Record (VoR)Open Access (License Unspecified) Open

Abstract

Granulocyte Colony-Stimulating Factor Granulocytes Humans Leukocyte Count Male Middle Aged Neutropenia - chemically induced Pancrelipase
A 61-year-old man was transferred to our facility from an outside hospital due to refractory neutropaenia of unknown aetiology. The patient presented to the referring hospital with a 5-day history of worsening diarrhoea and abdominal pain. Initial lab results at presentation showed severe neutropaenia with an absolute neutrophil count of 0. Investigations included a bone marrow biopsy which showed slightly hypocellular marrow with near absence of granulocytic precursors. A CT without contrast showed evidence of chronic pancreatitis and acute colitis. The patient's neutropaenia persisted despite granulocyte colony-stimulating factor therapy. The patient was, thus, transferred to our facility for a higher level of care. At our facility, the patient had rapid correction of neutropaenia after discontinuation of pancrelipase therapy. The patient's abdominal pain and diarrhoea also improved while off pancrelipase. Neutropaenia has completely resolved 6 weeks after discharge without any further therapy.

Metrics

12 Record Views
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Medicine, General & Internal
Logo image